This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.
Stocks · News reference
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Axogen is acquiring BioCircuit Technologies for $200 million to add sutureless NerveTape to its portfolio, funded by a public stock offering.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
B of A Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $52
B of A Securities analyst Travis Steed initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $52.
8-K filing — Axogen, Inc. (AXGN)
Filed: 2026-10-01 AccNo: 0000805928-26-000104 Size: 195 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Truist Securities Maintains Buy on Axogen, Lowers Price Target to $53